Results 241 to 250 of about 5,494,201 (309)

Knowledge and attitudes toward cancer clinical trials: a multi-national cross-sectional study in the Middle East and North Africa. [PDF]

BMC Cancer
Qutob IA, Elgarawany A, Aufy H, Soliman A, M Ayesh B, Eldaly AA, Seliem SM, Trabelsi R, Shaalan FT, Shehab F, Elgahamy AS, Marie RN, Alnatsha AIS, Hamdan FMI, Shaltout AE, AlNjoom Q, Hamza FE, Isa NZ, Aljamri MRA, Flifel EM, Kenza K, Bougafa F, Abdi SM, Abusabha SE, Adawi Y, Hameda M, Albaoni HK, Baroudi A, Awad E, Frere NO.   +29 more
europepmc   +1 more source

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos, Marwa Al‐Dubai, Denise Walther, Dominic Borie, Jan D. Lünemann, Marc Pawlitzki, Sven G. Meuth, Solveig Henneicke, Stefan Vielhaber, Stefanie Schreiber   +9 more
wiley   +1 more source

Publisher Correction: Evaluating a pathogen-specific IgG binding assay for rapid detection of healthcare-associated infections. [PDF]

Sci Rep
Karakullukçu A, Akker M, Kuşkucu MA, Aygün G, Dikmen Y.   +4 more
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Correction: Yunita et al. Scoping Review: The Role of Tocotrienol-Rich Fraction as a Potent Neuroprotective Agent. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 7691. [PDF]

Int J Mol Sci
Yunita E, Nasaruddin ML, Ramli NZ, Yahaya MF, Ahmad Damanhuri H.   +4 more
europepmc   +1 more source

Neurovascular Contacts in the Pathophysiology of Neuralgic Amyotrophy: An Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuralgic amyotrophy (NA) is a prevalent, monophasic, multifocal immune‐mediated neuropathy. A distinctive characteristic of the disease is the occurrence of nerve or fascicle constrictions and torsions (NA‐associated focal nerve lesions, NAFL). The pathophysiology underlying this phenomenon remains to be fully elucidated.
Johannes Fabian Holle, Andreas Leha, Volker Limmroth, Wolfram Windisch, Maximilian Zimmermann   +4 more
wiley   +1 more source

Elevating the University Teaching Qualification: From Ticking the Box to Actual Impact on Teaching. [PDF]

Perspect Med Educ
Biwer F, Loosveld LM, Compen B.
europepmc   +1 more source

Recurrent Hypothermia and Autonomic Dysfunction Secondary to Shapiro Syndrome

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT A 44‐year‐old man presented with recurrent hypothermia, diaphoresis and hypertension. Extensive investigation for infectious, inflammatory, metabolic and endocrine aetiologies was negative. MR scan of the brain demonstrated no lesions but revealed callosal dysgenesis, consistent with Shapiro syndrome.
Naveen Kumar, Jeremy Johnson, Susanne Watkins, Eoin Mulroy   +3 more
wiley   +1 more source

Design and Evaluation of a Faculty Development Workshop Series on Integrating Generative Artificial Intelligence in Medical Education: Mixed Methods Pilot Study. [PDF]

JMIR Med Educ
Anand R, Bowers N, Manyama MF.
europepmc   +1 more source

Participatory Action Research: Meaningful Student Involvement in Medical Curriculum Development. [PDF]

Clin Teach
Tyson Y, Al-Jawad M.
europepmc   +1 more source